![Michel Vounatsos](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Michel Vounatsos
Director/Miembro de la Junta en REVVITY, INC. .
Fortuna: 2 M $ al 31/05/2025
Perfil
Michel Vounatsos es miembro del consejo de administración de PerkinElmer, Inc. (Estados Unidos), LInstitut de RYthmologie et Modlisation Cardiaque y n-Lorem Foundation, y director general y consejero de Biogen, Inc. En su anterior carrera ocupó el cargo de Presidente de la Línea de Negocio de Atención Primaria y Clientes en Merck & Co. El Sr. Vounatsos obtuvo un MBA en la Escuela de Altos Estudios Comerciales de París.
Participaciones conocidas en empresas públicas
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
ZAI LAB LTD. 0,04 % | 18/06/2024 | 395.850 ( 0,04 % ) | 1 M $ | 31/05/2025 |
REVVITY, INC. 0,01 % | 30/04/2025 | 11.697 ( 0,01 % ) | 1 M $ | 31/05/2025 |
Últimas noticias acerca de Michel Vounatsos
Cargos activos de Michel Vounatsos
| Empresas | Cargo | Inicio |
|---|---|---|
| REVVITY, INC. | Director/Miembro de la Junta | 01/03/2020 |
| ZAI LAB LIMITED | Director/Miembro de la Junta | 07/01/2023 |
Biogen Idec, Inc. (North Carolina)
 Biogen Idec, Inc. (North Carolina) Pharmaceuticals: MajorHealth Technology Part of Biogen, Inc., Biogen Idec, Inc. (North Carolina) is a pharmaceutical company based in Durham, NC. The company develops pharmaceutical products. Michel Pericles Vounatsos has been the CEO of the company since 2016. | Director Ejecutivo | 06/01/2017 |
Biogen GmbH
 Biogen GmbH Pharmaceuticals: MajorHealth Technology Part of Biogen, Inc., Biogen GmbH is a pioneer in the field of neuroscience since 1978. The company is based in Ismaning, Germany. Biogen focuses on research in therapeutic areas with a strong emphasis on difficult-to-treat diseases. The German company was founded in 1978 by Charles Weissman, Kenneth Murray, Heinz Schaller, Phillip Sharp, Walter Gilbert. The CEO is Michel Pericles Vounatsos. | Director Ejecutivo | - |
L’Institut de RYthmologie et Modélisation Cardiaque | Presidente | - |
n-Lorem Foundation
 n-Lorem Foundation Miscellaneous Commercial ServicesCommercial Services n-Lorem Foundation is a non-profit organization that applies antisense technology to provide experimental antisense oligonucleotide (ASO) medicines for patients with ultra-rare diseases. These diseases are caused by a single genetic defect unique to only a few individuals. ASOs are modified DNA strands that target the transcripts of a defective gene to correct the abnormality. The advantage of experimental ASO medicines is their rapid development, cost-effectiveness, and high specificity. The company was founded by Stanley T. Crooke, Ph.D., who has been the CEO since incorporation. The company is based in Carlsbad. | Director/Miembro de la Junta | - |
Revvity BV
 Revvity BV Medical SpecialtiesHealth Technology PerkinElmer focuses on improving the health and safety of people and the environment. The company is headquartered in Zaventem, Belgium. | Director/Miembro de la Junta | - |
Antiguos cargos conocidos de Michel Vounatsos.
| Empresas | Cargo | Fin |
|---|---|---|
| BIOGEN INC. | Director Ejecutivo | 14/11/2022 |
| MERCK & CO., INC. | Corporate Officer/Principal | 01/04/2016 |
Formación de Michel Vounatsos.
École des Hautes Études Commerciales de Paris | Masters Business Admin |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 4 |
|---|---|
| BIOGEN INC. | Health Technology |
| MERCK & CO., INC. | Health Technology |
| REVVITY, INC. | Health Technology |
| ZAI LAB LIMITED | Health Technology |
| Empresas privadas | 5 |
|---|---|
Biogen Idec, Inc. (North Carolina)
Biogen Idec, Inc. (North Carolina) Pharmaceuticals: MajorHealth Technology Part of Biogen, Inc., Biogen Idec, Inc. (North Carolina) is a pharmaceutical company based in Durham, NC. The company develops pharmaceutical products. Michel Pericles Vounatsos has been the CEO of the company since 2016. | Health Technology |
Biogen GmbH
Biogen GmbH Pharmaceuticals: MajorHealth Technology Part of Biogen, Inc., Biogen GmbH is a pioneer in the field of neuroscience since 1978. The company is based in Ismaning, Germany. Biogen focuses on research in therapeutic areas with a strong emphasis on difficult-to-treat diseases. The German company was founded in 1978 by Charles Weissman, Kenneth Murray, Heinz Schaller, Phillip Sharp, Walter Gilbert. The CEO is Michel Pericles Vounatsos. | Health Technology |
L’Institut de RYthmologie et Modélisation Cardiaque | |
n-Lorem Foundation
n-Lorem Foundation Miscellaneous Commercial ServicesCommercial Services n-Lorem Foundation is a non-profit organization that applies antisense technology to provide experimental antisense oligonucleotide (ASO) medicines for patients with ultra-rare diseases. These diseases are caused by a single genetic defect unique to only a few individuals. ASOs are modified DNA strands that target the transcripts of a defective gene to correct the abnormality. The advantage of experimental ASO medicines is their rapid development, cost-effectiveness, and high specificity. The company was founded by Stanley T. Crooke, Ph.D., who has been the CEO since incorporation. The company is based in Carlsbad. | Commercial Services |
Revvity BV
Revvity BV Medical SpecialtiesHealth Technology PerkinElmer focuses on improving the health and safety of people and the environment. The company is headquartered in Zaventem, Belgium. | Health Technology |
- Bolsa de valores
- Insiders
- Michel Vounatsos
